Motilal Oswal Financial Services upgrades Biocon to Buy, target price Rs 430
buy call on Biocon with a target price of Rs 430. The current market price of Biocon is Rs 382.8. Biocon, incorporated in 1978, is a Large Cap company with a market cap of Rs 45970.97 crore, operating in the pharmaceuticals sector.
Biocon's key products/revenue segments include Bio Pharmaceuticals, Other Operating Revenue, Waste and Sale of services for the year ending 31-Mar-2024.
Financials For the quarter ended 30-09-2024, the company has reported a Consolidated Total Income of Rs 3622.90 crore, down -20.68% from last quarter Total Income of Rs 4567.40 crore and up .07% from last year same quarter Total Income of Rs 3620.20 crore. The company has reported net profit after tax of Rs 27.10 crore in the latest quarter.
The company's top management includes Ms.Kiran Mazumdar Shaw, Mr.Nicholas Robert Haggar, Ms.Rekha Mehrotra Menon, Mr.Naina Lal Kidwai, Mr.Bobby Kanubhai Parikh, Mr.Meleveetil Damodaran, Mr.Eric Vivek Mazumdar, Prof.Ravi Rasendra Mazumdar, Mr.Siddharth Mittal, Mr.Atul Dhawan. Company has B S R & Co. LLP as its auditors. As on 30-09-2024, the company has a total of 120 Crore shares outstanding.
Stock Trading
Masterclass on Value Investing and Company Valuation
Stock Trading
Market 104: Options Trading: Kickstart Your F&O Adventure
By — Saketh R, Founder- QuickAlpha, Full Time Options Trader
Stock Trading
Technical Analysis for Everyone — Technical Analysis Course
By — Abhijit Paul, Technical Research Head, Fund Manager- ICICI Securities
Stock Trading
Stock Markets Made Easy
By — elearnmarkets, Financial
